Close Menu

cancer sequencing

Additions to the company's portfolio in the last two years provide a broader footing for clinical NGS analysis and reporting workflows.

Researchers participating in ORIEN's Avatar program can use the platform to manage, share, integrate, and analyze molecular data from consenting patients.

HudsonAlpha researchers are expected to sequence 20,000 patient tumor and non-tumor samples for ORIEN's Avatar initiative by 2019.

The company recently released an RUO RNA extraction kit, and plans to launch a liquid biopsy pan-cancer test and disease-specific NGS panels later this year.

Backed by $12 million from a recent Series A financing and a strategic partnership with Thermo Fisher Scientific, the Ann Arbor, Michigan-based firm plans to sequence the tumors of 100,000 advanced cancer patients over three years.

The company reported 8,985 clinical tests in the first quarter, a 14 percent year-over-year increase.

The firm's $80 investment in Lasergen sets the stage for it to develop an integrated sample-to-result clinical genomics workflow by 2020.

The Wellcome Trust Sanger Institute spinout was working on combining genomic and clinical data sets to inform cancer diagnosis, prognosis, and treatment.

These are exciting times in oncology, but community oncologists need support to keep up with rapidly advancing science, said Lincoln Nadauld.

The study, which will be the pediatric counterpart to the ongoing adult-only NCI-MATCH trial, will be run by the NCI in partnership with the Children's Oncology Group.

Pages

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.